Onderneming Interpace Biosciences, Inc. Other OTC
Aandelen
IDXG
US46062X3035
Beheerde gezondheidszorg
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Diagnostic Clinical Services
100,0
%
| 32 | 100,0 % | 40 | 100,0 % | +26,31% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 32 | 100,0 % | 40 | 100,0 % | +26,31% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Thomas Burnell
CEO | Chief Executive Officer | 62 | 01-12-20 |
Director of Finance/CFO | 32 | 01-06-19 | |
Nicole Massoll
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Jody Campbell
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Vijay Aggarwal
BRD | Director/Board Member | 75 | 01-02-22 |
Joseph Keegan
BRD | Director/Board Member | 71 | 01-01-16 |
Stephen Sullivan
BRD | Director/Board Member | 77 | 01-09-04 |
Fortunato Rocca
BRD | Director/Board Member | 62 | 22-01-20 |
Thomas Burnell
CEO | Chief Executive Officer | 62 | 01-12-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 47 000 | 0 | 0 | 72,42 % |
Aandeel B | 1 | 4 472 442 | 3 239 074 ( 72,42 %) | 96 044 ( 2,147 %) |
Bedrijfsgegevens
Interpace Biosciences, Inc.
Waterview Plaza Suite 310
07054, Parsippany
+855 776 6419
http://www.interpacediagnostics.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-15,06% | 5,53 mld. | |
+0,60% | 1,26 mld. |